Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study.

Maria Juncal-Ruiz, Laura Riesco-Davila, Javier Vazquez-Bourgon, Victor Ortiz-Garcia de la Foz, Jacqueline Mayoral-Van Son, Rosa Ayesa-Arriola, Esther Setien-Suero, Juan Carlos Leza, Marcos Lopez-Hoyos, Benedicto Crespo-Facorro

Journal: International journal of molecular sciences 2021;21(17):6106

PMID: 32854231

Abstract

Toll-like receptors (TLRs) are a pivotal component of the innate immune system that seem to have a role in the pathogenesis of psychosis. The purpose of this work was to compare the expression and functionality of 9 TLRs in three peripheral blood mononuclear cells (PBMCs) (monocytes, B cells, and T cells) between 33 drug-naïve first-episode psychosis (FEP) individuals and 26 healthy volunteers, at baseline and after 3-month of antipsychotic treatment. The expression of TLRs 1-9 were assessed by flow cytometry. For the assessment of the TLR functionality, cells collected in sodium heparin tubes were polyclonally stimulated for 18 h, with different agonists for human TLR1-9. The results of our study highlight the role that TLR5 and TLR8 might play in the pathophysiology of psychosis. We found a lower expression of these receptors in FEP individuals, regarding healthy volunteers at baseline and after 3-month of treatment on the three PBMCs subsets. Most TLRs showed a lower functionality (especially reduced intracellular levels of TNF-α) in patients than in healthy volunteers. These results, together with previous evidence, suggest that individuals with psychosis might show a pattern of TLR expression that differs from that of healthy volunteers, which could vary according to the intensity of immune/inflammatory response.

Address: Department of Psychiatry, Hospital Sierrallana, IDIVAL, CIBERSAM, School of Medicine, University of Cantabria, 39300 Torrelavega, Spain.; Department of Immunology, Hospital Universitario A Coruña, 15006 A Coruña, Spain.; Department of Psychiatry, Hospital Universitario Marqués de Valdecilla, IDIVAL, CIBERSAM, School of Medicine, University of Cantabria, 39008 Santander, Spain.; Department of Psychiatry, Hospital Universitario Virgen del Rocío, Instituto de Investigacion Sanitaria de Sevilla (IBiS), CIBERSAM, School of Medicine, University of Sevilla, 41013 Sevilla, Spain.; Department of Pharmacology & Toxicology, Faculty of Medicine, Complutense University (UCM), Instituto de Investigación Sanitaria (IIS) Hospital 12 de Octubre (i+12), and IUIN-UCM, CIBERSAM, 28040 Madrid, Spain.; Department of Immunology, Hospital Universitario Marqués de Valdecilla, PI of "Transplant and Autoimmunity" Research Group, REDINREN RD16/0009/0027, IDIVAL, School of Medicine, University of Cantabria, 39008 Santander, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.